← back to search

Anne Le

Baker Heart and Diabetes Institute · AU
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer, Metabolomics and Mass Spectrometry Studies, and Mitochondrial Function and Pathology.
h-index
44
citations
10,216
works
189
NIH funding
primary concept
Medicine
email

Recent publications

Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation.
2025cited by 0position: contributordoi
Comprehensive proteogenomic characterization of rare kidney tumors
Cell Reports Medicine 2024cited by 44position: middledoi
Dual treatment with kynurenine pathway inhibitors and <scp>NAD</scp> <sup>+</sup> precursors synergistically extends life span in <i>Drosophila</i>
Aging Cell 2024cited by 14position: middledoi
Excoriation Disorder Is Characterized by Systemic Glutamatergic Dysfunction
Journal of Investigative Dermatology 2024cited by 0position: contributordoi
Metabolic Recycling Enhances Proliferation in MYC-Transformed Lymphoma B Cells.
2023cited by 1position: contributordoi
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell 2022cited by 202position: middledoi
Metabolomics-Based Identification of Metabolic Dysfunction in Frailty.
2022cited by 34position: contributordoi
Metabolic reservoir cycles in cancer.
2022cited by 23position: contributordoi
Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
2022cited by 6position: contributordoi
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice.
2021cited by 262position: contributordoi
Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Advances in experimental medicine and biology 2021cited by 220position: lastdoi
Glucose Metabolism in Cancer: The Warburg Effect and Beyond.
2021cited by 150position: contributordoi
Glutamine Metabolism in Cancer.
2021cited by 87position: contributordoi
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment.
2021cited by 61position: contributordoi
The limitless applications of single-cell metabolomics.
2021cited by 55position: contributordoi
The Heterogeneity of Liver Cancer Metabolism.
2021cited by 40position: contributordoi
The Heterogeneity of Lipid Metabolism in Cancer.
2021cited by 30position: contributordoi
Different Tumor Microenvironments Lead to Different Metabolic Phenotypes.
2021cited by 25position: contributordoi
The Intratumoral Heterogeneity of Cancer Metabolism.
2021cited by 22position: contributordoi
The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.
2021cited by 21position: contributordoi
The Heterogeneity of Breast Cancer Metabolism.
2021cited by 20position: contributordoi
Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules.
2021cited by 20position: contributordoi
The Intricate Metabolism of Pancreatic Cancers.
2021cited by 9position: contributordoi
Diabetes and Cancer: The Epidemiological and Metabolic Associations.
2021cited by 6position: contributordoi
Uncovering metabolic reservoir cycles in MYC-transformed lymphoma B cells using stable isotope resolved metabolomics.
2021cited by 5position: contributordoi
The Heterogeneity Metabolism of Renal Cell Carcinomas.
2021cited by 3position: contributordoi
Barth syndrome cellular models have dysregulated respiratory chain complex I and mitochondrial quality control due to abnormal cardiolipin
2021cited by 0position: contributordoi
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
Nature Biotechnology 2020cited by 337position: middledoi
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
2020cited by 75position: contributordoi
Kynurenines link chronic inflammation to functional decline and physical frailty.
2020cited by 74position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 13 papers (2019–2024)Chi V. Dang · Johns Hopkins University4 papers (2012–2015)Yao-An Shen · Jinling Institute of Technology3 papers (2019–2021)Sminu Bose · Memorial Sloan Kettering Cancer Center3 papers (2012–2021)Dean W. Felsher · Stanford Health Care3 papers (2015–2021)Barbara S. Slusher · Johns Hopkins University3 papers (2012–2016)Cissy Zhang · Johns Hopkins Medicine2 papers (2020–2021)Steven Michael Claypool · Indiana University School of Medicine2 papers (2021–2021)Simion Kreimer · Mills College2 papers (2021–2021)Qian-Li Xue · Henan Medical University2 papers (2020–2022)Hilary J. Vernon · Johns Hopkins University2 papers (2021–2021)Brian James Kirsch · 2 papers (2021–2021)Robert N. Cole · Protéomique, Réponse Inflammatoire et Spectrométrie de Masse2 papers (2021–2021)Veronica Francis Busa · German Cancer Research Center2 papers (2021–2021)Olivia Sniezek · Johns Hopkins University2 papers (2021–2021)Arianna F. Anzmann · Johns Hopkins University2 papers (2021–2021) · 2 papers (2021–2021)Alexandra Pado · Johns Hopkins University2 papers (2021–2021)Nabeel Attarwala · Cornell University2 papers (2020–2021)Frédéric M. Vaz · Emma Kinderziekenhuis2 papers (2021–2021)